DE69831620D1 - Arzneizubereitungen enthaltend Kannabinoide - Google Patents
Arzneizubereitungen enthaltend KannabinoideInfo
- Publication number
- DE69831620D1 DE69831620D1 DE69831620T DE69831620T DE69831620D1 DE 69831620 D1 DE69831620 D1 DE 69831620D1 DE 69831620 T DE69831620 T DE 69831620T DE 69831620 T DE69831620 T DE 69831620T DE 69831620 D1 DE69831620 D1 DE 69831620D1
- Authority
- DE
- Germany
- Prior art keywords
- pharmaceutical preparations
- preparations containing
- containing cannabinoids
- cannabinoids
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Otolaryngology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Hospice & Palliative Care (AREA)
- Neurology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9726916.1A GB9726916D0 (en) | 1997-12-19 | 1997-12-19 | Nasal formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69831620D1 true DE69831620D1 (de) | 2005-10-20 |
Family
ID=10823941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69831620T Expired - Lifetime DE69831620D1 (de) | 1997-12-19 | 1998-12-10 | Arzneizubereitungen enthaltend Kannabinoide |
Country Status (13)
Country | Link |
---|---|
US (1) | US6383513B1 (de) |
EP (2) | EP1039898A1 (de) |
JP (1) | JP2001526221A (de) |
AR (1) | AR017898A1 (de) |
AT (1) | ATE304351T1 (de) |
AU (1) | AU756669B2 (de) |
CA (1) | CA2313316A1 (de) |
DE (1) | DE69831620D1 (de) |
GB (1) | GB9726916D0 (de) |
NO (1) | NO20003161L (de) |
NZ (1) | NZ504679A (de) |
WO (1) | WO1999032107A1 (de) |
ZA (1) | ZA9811528B (de) |
Families Citing this family (86)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7022683B1 (en) * | 1998-05-13 | 2006-04-04 | Carrington Laboratories, Inc. | Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation |
US7662409B2 (en) | 1998-09-25 | 2010-02-16 | Gel-Del Technologies, Inc. | Protein matrix materials, devices and methods of making and using thereof |
US6566560B2 (en) | 1999-03-22 | 2003-05-20 | Immugen Pharmaceuticals, Inc. | Resorcinolic compounds |
US6747058B1 (en) | 1999-08-20 | 2004-06-08 | Unimed Pharmaceuticals, Inc. | Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor |
US7648696B2 (en) | 1999-08-20 | 2010-01-19 | Unimed Pharmaceuticals, Llc | Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent |
EP1280515B1 (de) * | 2000-03-09 | 2007-02-14 | GW Pharma Limited | Cannabis enthaltende pharmazeutische zusammensetzungen |
GB2361869B (en) * | 2000-03-09 | 2004-09-22 | Pharmasol Ltd | Sublingual delivery of cannabis |
US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
WO2002064109A2 (en) * | 2001-02-14 | 2002-08-22 | Gw Pharma Limited | Mucoadhesive pharmaceutical formulations |
US10004684B2 (en) | 2001-02-14 | 2018-06-26 | Gw Pharma Limited | Pharmaceutical formulations |
US6777000B2 (en) * | 2001-02-28 | 2004-08-17 | Carrington Laboratories, Inc. | In-situ gel formation of pectin |
US7494669B2 (en) * | 2001-02-28 | 2009-02-24 | Carrington Laboratories, Inc. | Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
DK1389089T3 (da) * | 2001-03-27 | 2009-12-21 | Phares Pharm Res Nv | Fremgangsmådeog sammensætning til solubilisering af en biologisk aktiv forbindelse med lav vandoplöselighed |
WO2003006010A1 (en) * | 2001-07-10 | 2003-01-23 | Norton Healthcare Limited | Aerosol formulations of δ8 tetrahydrocannabinol |
EP1321159A1 (de) * | 2001-12-21 | 2003-06-25 | CHIESI FARMACEUTICI S.p.A. | Betätigungsvorrichtung für Druckdosierinhalator mit lasergebohrten Löchern |
GB0202385D0 (en) * | 2002-02-01 | 2002-03-20 | Gw Pharma Ltd | Compositions for the treatment of nausea,vomiting,emesis,motion sicknes or like conditions |
ES2305437T3 (es) * | 2002-02-01 | 2008-11-01 | Resolution Chemicals Limited | Produccion de delta-9 tetrahidrocannabinol. |
EP1482917B1 (de) * | 2002-02-01 | 2019-05-08 | GW Pharma Limited | Zusammensetzungen mit cannabidiolsäure zur behandlung von übelkeit, erbrechen, emesis, reisekrankheit oder ähnlichen zuständen |
IL148244A0 (en) | 2002-02-19 | 2002-09-12 | Yissum Res Dev Co | Anti-nausea and anti-vomiting activity of cannabidiol compounds |
FI113340B (fi) | 2002-02-20 | 2004-04-15 | Tomi Jaervinen | Uudet luonnon syklodekstriinin kompleksit |
FI20020333A0 (fi) | 2002-02-20 | 2002-02-20 | Tomi Jaervinen | Metyloidun syklodekstriinin uudet kompleksit |
CA2480270A1 (en) * | 2002-04-03 | 2003-10-09 | Solvay Pharmaceuticals B.V. | Stabilized natural cannabinoid formulation |
AR039194A1 (es) | 2002-04-03 | 2005-02-09 | Solvay Pharm Bv | Formulacion de cannabinoides naturales estabilizados |
WO2003101357A1 (en) * | 2002-05-31 | 2003-12-11 | University Of Mississippi | Transmucosal delivery of cannabinoids |
US20040077540A1 (en) * | 2002-06-28 | 2004-04-22 | Nastech Pharmaceutical Company Inc. | Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds |
US20040228921A1 (en) * | 2003-02-14 | 2004-11-18 | Chowdhury Dipak K. | Compositions and methods for delivery of therapeutic agents |
WO2004092101A2 (en) * | 2003-04-10 | 2004-10-28 | Mallinckrodt Inc. | Olivetol-cyclodextrin complexes and regio-selective process for preparing delta 9-tetrahydrocannabinol |
CN100575955C (zh) * | 2003-04-30 | 2009-12-30 | 纳斯泰克制药公司 | 密蛋白的未表达作为肿瘤转移的标记物 |
CA2524286A1 (en) * | 2003-05-01 | 2004-11-18 | West Pharmaceutical Services Drug Delivery & Clinical Research Centre Li Mited | Nasal administration of the lh-rh analog leuprolide |
US8529939B2 (en) * | 2003-12-08 | 2013-09-10 | Gel-Del Technologies, Inc. | Mucoadhesive drug delivery devices and methods of making and using thereof |
US20050129679A1 (en) * | 2003-12-15 | 2005-06-16 | Nastech Pharmaceutical Company Inc. | Method for opening tight junctions |
US7906140B2 (en) * | 2004-06-17 | 2011-03-15 | Virun, Inc. | Compositions for mucosal delivery of agents |
US20060078955A1 (en) * | 2004-10-13 | 2006-04-13 | Lin-Zhi International | Method for retrieving delta9-THC from oral fluid |
TWI369203B (en) | 2004-11-22 | 2012-08-01 | Euro Celtique Sa | Methods for purifying trans-(-)-△9-tetrahydrocannabinol and trans-(+)-△9-tetrahydrocannabinol |
KR20070118069A (ko) * | 2004-12-09 | 2007-12-13 | 인시스 테라퓨틱스, 인코포레이티드 | 실온에서 안정한 드로나비놀 제형 |
TWI366460B (en) * | 2005-06-16 | 2012-06-21 | Euro Celtique Sa | Cannabinoid active pharmaceutical ingredient for improved dosage forms |
US20070060639A1 (en) * | 2005-09-09 | 2007-03-15 | University Of Kentucky | Compositions and methods for intranasal delivery of tricyclic cannabinoids |
ES2581212T3 (es) * | 2005-11-07 | 2016-09-02 | Murty Pharmaceuticals, Inc. | Administración mejorada de tetahidrocannabinol |
KR20080111033A (ko) * | 2006-03-29 | 2008-12-22 | 후지필름 가부시키가이샤 | 카제인 나노입자 |
AU2007281918A1 (en) * | 2006-08-04 | 2008-02-14 | Insys Therapeutics Inc. | Aqueous dronabinol formulations |
US20100034888A1 (en) * | 2006-09-15 | 2010-02-11 | Hubert Clemens Pellikaan | Granulate containing a pharmaceutically active substance and method for its manufacture |
US8039509B2 (en) | 2006-11-10 | 2011-10-18 | Johnson Matthey Public Limited Company | Composition comprising (−)-Δ9-trans-tetrahydrocannabinol |
US8980940B2 (en) | 2006-11-10 | 2015-03-17 | Johnson Matthey Public Limited Company | Stable cannabinoid compositions and methods for making and storing them |
WO2009020666A1 (en) * | 2007-08-06 | 2009-02-12 | Insys Therapeutics Inc. | Oral cannabinoid liquid formulations and methods of treatment |
US8735374B2 (en) | 2009-07-31 | 2014-05-27 | Intelgenx Corp. | Oral mucoadhesive dosage form |
US10610528B2 (en) | 2009-12-08 | 2020-04-07 | Intelgenx Corp. | Solid oral film dosage forms and methods for making same |
US20110136815A1 (en) | 2009-12-08 | 2011-06-09 | Horst Zerbe | Solid oral film dosage forms and methods for making same |
US8808734B2 (en) * | 2011-07-11 | 2014-08-19 | Full Spectrum Laboratories Limited | Cannabinoid formulations |
EP3119391A4 (de) | 2014-03-18 | 2017-12-27 | Izun Pharmaceuticals Corp. | Proteingebundene cannabinoidzusammensetzungen |
GB2530001B (en) | 2014-06-17 | 2019-01-16 | Gw Pharma Ltd | Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy |
WO2015200049A1 (en) | 2014-06-26 | 2015-12-30 | Island Breeze Systems Ca, Llc | Mdi related products and methods of use |
GB2531282A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabinoids in the treatment of epilepsy |
US20160143972A1 (en) * | 2014-11-21 | 2016-05-26 | Cannamark Inc. | Method and apparatus for preparing a solid form of cannabinoid |
US10406186B2 (en) | 2015-01-31 | 2019-09-10 | Constance Therapeutics, Inc. | Cannabis oil extracts and compositions |
AU2016231788A1 (en) * | 2015-03-19 | 2017-10-12 | One World Cannabis Ltd | Preparations of cannabis emulsions and methods thereof |
GB2539472A (en) | 2015-06-17 | 2016-12-21 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
BR102015024165A2 (pt) * | 2015-09-18 | 2017-03-28 | Prati Donaduzzi & Cia Ltda | composição farmacêutica oral compreendendo canabinóide, processo para sua preparação e seu uso |
EP3380096A4 (de) * | 2015-11-24 | 2019-10-23 | Constance Therapeutics, Inc. | Cannabisölzusammensetzungen und verfahren zur herstellung davon |
WO2017127641A1 (en) * | 2016-01-20 | 2017-07-27 | Flurry Powders | Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation |
US11833118B2 (en) | 2016-01-20 | 2023-12-05 | Flurry Powders, Llc | Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation |
JP7053054B2 (ja) * | 2016-04-15 | 2022-04-12 | エスアールイー ウェルネス,インク. | 大麻注入甘味料及び他の組成物 |
JP2019511580A (ja) | 2016-04-15 | 2019-04-25 | エスアールイー ウェルネス インク.Sre Wellness Inc. | 乳化剤を使用して大麻油を親水性にする方法及び関連するカンナビノイド組成物 |
US10499584B2 (en) | 2016-05-27 | 2019-12-10 | New West Genetics | Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles |
KR102433459B1 (ko) * | 2016-06-02 | 2022-08-17 | 아세러스 랩스 인코포레이티드 | 칸나비노이드의 반고체 및 점성 액체 비강 제형 |
US20180085308A1 (en) * | 2016-09-27 | 2018-03-29 | CannTab Therapeutics Limited | Sustained release cannabinoid formulations |
WO2018152334A1 (en) * | 2017-02-15 | 2018-08-23 | Molecular Infusions, Llc | Formulations |
IL269100B1 (en) * | 2017-03-09 | 2024-01-01 | Izun Pharmaceuticals Corp | Stabilized cannabinoid compounds are bound to protein |
WO2018167795A1 (en) * | 2017-03-16 | 2018-09-20 | Izun Pharmaceuticals Corp. | Cannabinoid formulations and dosage |
EP3644986A4 (de) * | 2017-05-01 | 2021-01-06 | MJ Wooly Corporation | Methodologie und formulierung zur erzeugung von pulver einer verkapselten, cannabisbasierten komponente, die in einer polymermatrix eingebettet ist |
US10058531B1 (en) | 2017-06-01 | 2018-08-28 | Spartak LLC | Dosage delivery film |
WO2018232362A1 (en) * | 2017-06-16 | 2018-12-20 | Tarukino Holdings, Inc. | Preparing stable liquid emulsion forms of plant extract |
EP4356965A2 (de) * | 2017-07-14 | 2024-04-24 | 5071, Inc. | Cannabinoidzusammensetzungen und verfahren zur herstellung davon |
WO2019106652A1 (en) | 2017-11-29 | 2019-06-06 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Cannabinoids compositions and methods |
MX2020003661A (es) * | 2017-11-30 | 2020-08-03 | Canopy Growth Corp | Formas de dosificacion de liquidos, metodos de fabricacion y uso. |
US20200330378A1 (en) * | 2018-01-03 | 2020-10-22 | Icdpharma Ltd. | Taste-enhanced cannabinoid submicron emulsion syrup compositions |
GB201806953D0 (en) | 2018-04-27 | 2018-06-13 | Gw Res Ltd | Cannabidiol Preparations |
WO2019211771A1 (en) * | 2018-05-03 | 2019-11-07 | Radient Technologies Inc. | Water soluble and water dispersible formulations of cannabinoids |
WO2020016659A2 (en) | 2018-07-18 | 2020-01-23 | Glatt Gmbh | Multiparticulate formulations of cannabinoids |
US10383819B1 (en) | 2018-07-23 | 2019-08-20 | Callitas Therapeutics, Inc. | Method to effect biphasic bioavailability of oral euphoric psychogenic cannabinoids |
WO2020097434A1 (en) * | 2018-11-08 | 2020-05-14 | Golfetto Michael | Compound delivery systems and methods of production |
EP3969143A4 (de) * | 2019-05-13 | 2023-09-06 | Buzzkill Labs, Inc. | Prozesskartusche für tragbares medikamententestsystem |
DE102019211195A1 (de) * | 2019-07-26 | 2021-01-28 | Add Advanced Drug Delivery Technologies Ltd. | Verfahren und Vorrichtung zur Herstellung eines im Wesentlichen im wässrigen Milieu lösbaren Cannabinoid-Granulats |
KR20220110730A (ko) * | 2019-10-21 | 2022-08-09 | 이솔레이트 엘티디 | 초미세 화합물 및 이의 제조 |
CN112891310A (zh) * | 2019-12-03 | 2021-06-04 | 晨光生物科技集团股份有限公司 | 一种大麻二酚粉末的制备方法、制备得到的大麻二酚粉末及其用途 |
EP3919046A1 (de) | 2020-06-02 | 2021-12-08 | Athenion AG | Verfahren zur solubilisierung von natürlichen, endogenen und synthetischen cannabinoiden |
MX2023000574A (es) | 2020-07-17 | 2023-03-14 | Canna Chemistries Llc | Composiciones sólidas de ?9 -tetrahidrocannabinol (?9 -thc). |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0266443B1 (de) * | 1986-11-03 | 1993-06-23 | Allen W. Jacobs | Verfahren zur Beimischung einer festen teilchenförmigen Komponente in Aerosolpräparate zur Inhalation des Nikotins |
US4464378A (en) * | 1981-04-28 | 1984-08-07 | University Of Kentucky Research Foundation | Method of administering narcotic antagonists and analgesics and novel dosage forms containing same |
GB8723846D0 (en) | 1987-10-10 | 1987-11-11 | Danbiosyst Ltd | Bioadhesive microsphere drug delivery system |
US6096740A (en) * | 1990-11-06 | 2000-08-01 | Ramot University Authority For Applied Research And Industrial Development Ltd. | Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions |
US5576016A (en) * | 1993-05-18 | 1996-11-19 | Pharmos Corporation | Solid fat nanoemulsions as drug delivery vehicles |
US5961970A (en) * | 1993-10-29 | 1999-10-05 | Pharmos Corporation | Submicron emulsions as vaccine adjuvants |
US5447729A (en) * | 1994-04-07 | 1995-09-05 | Pharmavene, Inc. | Multilamellar drug delivery systems |
IL115245A (en) * | 1995-09-11 | 2002-12-01 | Yissum Res Dev Co | Tumor necrosis factor inhibiting pharmaceuticals |
US6017963A (en) * | 1995-11-14 | 2000-01-25 | Euro-Celtique, S.A. | Formulation for intranasal administration |
JP2001507702A (ja) * | 1996-12-31 | 2001-06-12 | インヘイル・セラピューティックス・システムズ・インコーポレテッド | 親水性賦形剤を有する疎水性薬剤の水性懸濁液を噴霧乾燥させる方法およびその方法によって作製された組成物 |
US5804592A (en) * | 1997-05-30 | 1998-09-08 | Unimed Pharmaceuticals, Inc. | Method for improving disturbed behavior and elevating mood in humans |
US5989535A (en) * | 1997-08-15 | 1999-11-23 | Soma Technologies | Polymeric bioadhesive emulsions and suspensions and methods of treatment |
-
1997
- 1997-12-19 GB GBGB9726916.1A patent/GB9726916D0/en not_active Ceased
-
1998
- 1998-12-10 AU AU14972/99A patent/AU756669B2/en not_active Ceased
- 1998-12-10 JP JP2000525098A patent/JP2001526221A/ja active Pending
- 1998-12-10 CA CA002313316A patent/CA2313316A1/en not_active Abandoned
- 1998-12-10 NZ NZ504679A patent/NZ504679A/en unknown
- 1998-12-10 EP EP98959041A patent/EP1039898A1/de not_active Withdrawn
- 1998-12-10 WO PCT/GB1998/003703 patent/WO1999032107A1/en not_active Application Discontinuation
- 1998-12-10 EP EP04075590A patent/EP1437136B1/de not_active Expired - Lifetime
- 1998-12-10 AT AT04075590T patent/ATE304351T1/de not_active IP Right Cessation
- 1998-12-10 DE DE69831620T patent/DE69831620D1/de not_active Expired - Lifetime
- 1998-12-15 ZA ZA9811528A patent/ZA9811528B/xx unknown
- 1998-12-18 AR ARP980106475A patent/AR017898A1/es unknown
-
2000
- 2000-06-16 US US09/595,086 patent/US6383513B1/en not_active Expired - Fee Related
- 2000-06-16 NO NO20003161A patent/NO20003161L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA9811528B (en) | 2000-10-12 |
AU1497299A (en) | 1999-07-12 |
EP1437136A1 (de) | 2004-07-14 |
AR017898A1 (es) | 2001-10-24 |
CA2313316A1 (en) | 1999-07-01 |
EP1039898A1 (de) | 2000-10-04 |
NO20003161D0 (no) | 2000-06-16 |
JP2001526221A (ja) | 2001-12-18 |
WO1999032107A1 (en) | 1999-07-01 |
AU756669B2 (en) | 2003-01-23 |
NO20003161L (no) | 2000-06-16 |
EP1437136B1 (de) | 2005-09-14 |
US6383513B1 (en) | 2002-05-07 |
GB9726916D0 (en) | 1998-02-18 |
NZ504679A (en) | 2002-06-28 |
ATE304351T1 (de) | 2005-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69831620D1 (de) | Arzneizubereitungen enthaltend Kannabinoide | |
DE69814091D1 (de) | Voriconazol-enthaltende pharmazeutische zubereitungen | |
IS5953A (is) | Lyfjablöndur úr örgerðum eplerenonum | |
DK0981375T3 (da) | Farmaceutiske præparater indeholdende plasmaprotein | |
DE69800639T2 (de) | Tetrahydrolipstatin enthaltende präparate | |
ID24654A (id) | Formulasi farmasi omeprazola | |
NO20001776D0 (no) | Medikamenter | |
BR9610153A (pt) | Formulações farmacêuticas | |
BR9611626A (pt) | Formulações farmacéuticas | |
NO995712D0 (no) | Oftalmiske preparater | |
NO980546D0 (no) | Farmasöytiske midler | |
ATE332132T1 (de) | Verbesserte arzneizubereitungen enthaltend ritonavir | |
DK1017392T3 (da) | Lægemiddel | |
DE59801987D1 (de) | Pharmazeutische zusammensetzung enthaltend peptichemio | |
DK0925273T3 (da) | Farmaceutiske præparater indeholdende 4-oxo-butansyrer | |
NO994619L (no) | Farmasöytiske blandinger | |
DE69926012D1 (de) | Arzneizubereitungen | |
MA26531A1 (fr) | Composition pharmaceutique | |
DK1041966T3 (da) | Farmaceutiske præparater omfattende zafirlukast | |
ITMI941169A0 (it) | Formulazioni farmaceutiche | |
EE03511B1 (et) | Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid | |
FI973230A (fi) | Uusi farmaseuttinen formulaatio | |
DE69906934D1 (de) | Arzneizubereitungen | |
FI951155A0 (fi) | Farmaseuttinen valmiste | |
DE29618094U1 (de) | Pharmazeutisches Präparat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |